PATENT CLAIM ANALYSIS

Application Number: 16244371
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["544", "250000"]

Abstract:
The present invention provides, inter alia, compounds capable of inhibiting NF-κB. Pharmaceutical compositions containing and methods of using the compounds are also provided herein.

Claim (Index 1):
A method of inhibiting NF-\u03baB in a cell, comprising: contacting the cell with a compound, wherein the compound is selected from the group consisting of and hydrates or pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.16667
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15393507', '13035640', '11849230', '12396084', '14384237']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493250697686131
- 35 USC 102 Novelty (BERT): 0.5348174762095594
- Combined Prediction Score: 0.7278743104127078
- Mean Citation Score: 257.72868800000003
- Max Citation Score: 381.4929
- Similarity Product: 321.3686921649814

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test